Please login to the form below

Not currently logged in
Email:
Password:

Former Pfizer R&D head LaMattina to advise Ziarco

He previously spent 30 years at US pharma firm

Dr John LaMattina ZiarcoUK-based biotech Ziarco has hired former head of R&D at Pfizer, Dr John LaMattina, as a strategic R&D adviser.

Dr LaMattina spent 30 years at Pfizer in total, including four years as president of global research and development from 2003 until his retirement from the US pharma giant in 2007.

Earlier roles he held at Pfizer included senior VP of worldwide development and chief medical officer.

In his new role, he will help Ziarco to advance its development strategies for its investigational compounds to tackle inflammatory and allergic diseases.

These include a H4 agonist that has just completed a phase I study.

In addition to his role at Ziarco, LaMattina is a senior partner at PureTech Venues and serves on the board of directors at Ligand Pharmaceuticals and the scientific advisory board of Trevena Pharmaceuticals.

20th March 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics